Mckesson Medical-Surgical Inc. Corporate Office 2022-08-17 Health serious FDA
Health · FDA · Recall #FDA-D-1324-2022
Asthmanefrin Racephinephrine Inhalation Solution Bronchodilator, For temporary relief of… Recall
Issued August 17, 2022 · Mckesson Medical-Surgical Inc. Corporate Office
In August 2022, Mckesson Medical-Surgical Inc. Corporate Office recalled the Asthmanefrin Racephinephrine Inhalation Solution Bronchodilator, For temporary relief of…, a serious health recall reported by the FDA. Affected owners are eligible for a voluntary. Here is what the hazard is and exactly what to do about it.
Compiled by Maya Ellison, RecallCheckr
What this means for you
CGMP Deviations: products were stored outside the drug label specifications.
What you should do
- 1 Stop using Asthmanefrin Racephinephrine Inhalation Solution Bronchodilator, For temporary relief of… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Mckesson Medical-Surgical Inc. Corporate Office to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Mckesson Medical-Surgical Inc. Corporate Office
- Category
- Health
- Recall date
- August 17, 2022
- Units affected
- Not reported
- Sold at
- Nationwide in the USA.
- Recall number
- FDA-D-1324-2022
- Made in
- United States
- Issuing agency
- FDA
In context
- Mckesson Medical-Surgical Inc. Corporate Office has 76 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 870th Health recall we've logged in 2022.